Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study

Lung adenocarcinoma (LUAD) is a non-small-cell lung cancer and is the leading cause of cancer-related deaths worldwide. Immunotherapy is a promising candidate for LUAD, and tumor mutation burden (TMB) could be a new biomarker to monitor the response of cancer patients to immunotherapy. It is known t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tingjun, Wu, Lianlian, Liu, Jing, Chen, Hao, Zhu, Bao, Qiao, Dandan, Zhu, Yuhua, Liu, Tingya, Chen, Quangang, Hu, Ankang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627637/
https://www.ncbi.nlm.nih.gov/pubmed/37932988
http://dx.doi.org/10.1097/MD.0000000000035481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627637/
https://www.ncbi.nlm.nih.gov/pubmed/37932988
http://dx.doi.org/10.1097/MD.0000000000035481

Ejemplares similares